# Evaluation of the Clinical Benefit of the Hearing Aids Tinnitus Feature.

> **NCT05292534** · NA · COMPLETED · sponsor: **Sonova AG** · enrollment: 38 (actual)

## Conditions studied

- Hearing Loss, Sensorineural
- Tinnitus

## Interventions

- **DEVICE:** hearing aid amplification
- **DEVICE:** hearing aid amplification with an added sound

## Key facts

- **NCT ID:** NCT05292534
- **Lead sponsor:** Sonova AG
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-06-01
- **Primary completion:** 2023-09-20
- **Final completion:** 2023-09-20
- **Target enrollment:** 38 (ACTUAL)
- **Last updated:** 2024-07-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05292534

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05292534, "Evaluation of the Clinical Benefit of the Hearing Aids Tinnitus Feature.". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT05292534. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*